Literature DB >> 35290153

Epidemiology of extrapulmonary tuberculosis among pediatric inpatients in mainland China: a descriptive, multicenter study.

Ping Chu1, Yan Chang1, Xuan Zhang1, Shujing Han1, Yaqiong Jin1, Yongbo Yu1, Yeran Yang1, Guoshuang Feng2, Xinyu Wang2, Ying Shen3, Xin Ni1,4, Yongli Guo1, Jie Lu1.   

Abstract

ABSTRACTPediatric tuberculosis (TB) is a serious infectious disease that affects many children worldwide and is more likely to be extrapulmonary than adult TB. However, the clinical and epidemiological profile, and cost burden of pediatric extrapulmonary TB (EPTB) in China remain unknown. Here, we conducted a descriptive, multicenter study of pediatric TB patients from 22 hospitals across all six regions in China from October 2015 to December 2018. Of 4,654 patients, 54.23% (2,524) had pulmonary TB (PTB), 17.76% (827) had EPTB, and 28.00% (1,303) had concurrent extrapulmonary and pulmonary TB (combined TB). Compared with PTB, EPTB and combined TB were associated with lower hospitalization frequency (2.43 and 2.21 vs. 3.16 times), longer length of stay (10.61 and 11.27 vs. 8.56 days), and higher rate of discharge against medical advice (8.46% and 9.44% vs. 5.67%). EPTB was associated with higher mortality (0.97% vs. 0.24% and 0.31%), higher rate of low birth weight (17.69% vs. 6.79% and 6.22%), worse diagnosis at the first visit (21.16% vs. 34.67% and 44.47%), and worse hospitalization plan situation (4.35% vs. 7.81% and 7.44%), compared with PTB and combined TB. EPTB and combined TB had higher financial burdens (17.67% and 16.94% vs. 13.30%) and higher rates of catastrophic expenditure (8.22% and 9.59% vs. 5.03%), compared with PTB. Meningitis TB (34.18%) was the most frequent form of total extrapulmonary infection and had the highest cost burden and rate of catastrophic expenditure. In conclusion, improved screening approaches for pediatric EPTB are needed to reduce diagnostic challenges and financial burden.

Entities:  

Keywords:  China; Extrapulmonary tuberculosis; children; epidemiology; inpatients

Mesh:

Year:  2022        PMID: 35290153      PMCID: PMC9009909          DOI: 10.1080/22221751.2022.2054367

Source DB:  PubMed          Journal:  Emerg Microbes Infect        ISSN: 2222-1751            Impact factor:   19.568


Introduction

Globally, tuberculosis (TB) is among the 10 most common causes of death; it is the main cause of infectious disease-related death[1, 2]. According to the World Health Organization, there were approximately 10.0 million TB cases worldwide in 2019[1]. Pediatric patients (aged < 15 years) with TB constituted approximately 12% of all cases worldwide; this rate has increased annually[2]. Because of gaps in diagnosis and access to care, pediatric TB is associated with a high mortality rate[3]. A mathematical modelling study showed that one in four pediatric TB patients die from the disease[4]. Therefore, pediatric TB is a serious infectious disease that affects many children worldwide; global TB management approaches should prioritize improvements in diagnosis, treatment, and prevention[5]. In addition to the lungs, TB affects many extrapulmonary sites; this is known as extrapulmonary TB (EPTB)[6]. The Global TB Report 2020[1] found that EPTB constituted 16% of notified TB cases worldwide; its proportion ranged from 8% in the Western Pacific Region to 24% in the Eastern Mediterranean Region. In clinical practice, EPTB at an obscure site is often incidentally detected [7]. Because of nonspecific symptoms and signs, along with a lack of constitutional features, EPTB is often not suspected early in the course of illness and remains a delayed diagnosis. Notably, TB is more likely to cause more severe disease in children than in adults; it is also more likely to be extrapulmonary[8]. To our knowledge, there have been few large-scale epidemiological studies of pediatric TB in China. Data regarding the prevalence of TB in children are often cited from the fourth nationwide random survey of TB, which was reported in 2002[9]. In 2005, the Chinese Centre for Disease Control and Prevention developed a web-based Tuberculosis Information Management System for real-time collection of TB data, including data regarding pediatric TB, in 31 provinces in mainland China[10]. However, centralized reporting is only required for pulmonary TB (PTB), not EPTB, according to the Chinese Law of Preventing and Controlling Infectious Disease. Moreover, children with TB are treated at pediatric or large general hospitals, which are not directly linked to the Tuberculosis Information Management System [11]. Therefore, epidemiological trends regarding forms of pediatric EPTB remain unclear. Thus far, only two single-centre studies have reported EPTB data. A descriptive study of 1212 patients aged 0–18 years with TB (655 cases with extrapulmonary infection, 54%) was conducted from January 2002 to December 2010 in Beijing Children’s Hospital [12]. Another study analyzed 1577 consecutive patients with pediatric TB (1137 cases with extrapulmonary infection, 73%) at a Referral Tuberculosis Hospital in Shandong Province [13]. However, multicenter pediatric EPTB data remain unavailable in China. Here, we retrospectively reviewed the epidemiological data and burden of pediatric EPTB among patients from nine provincial and 13 municipal hospitals in mainland China from October 2015 to December 2018. We aimed to determine patient characteristics, clinical and epidemiological profiles, and cost burden of pediatric EPTB in China.

Materials and methods

Data source

This retrospective study obtained discharge data from the Futang Research Centre of Pediatric Development (FRCPD), which is affiliated with the National Centre for Children’s Health, China. The FRCPD was founded and established as a multi-tiered pediatric diagnosis and treatment network; it includes 47 provincial and municipal level member hospitals, along with 3000 primary level pediatric institutions. Detailed information regarding the FRCPD is available at http://www.futang.org/about/fu-tang-jie-shao.htm. The data in our study were collected from nine provincial and 13 municipal hospitals in 21 provinces across all six regions in China from October 2015 to December 2018. The data were acquired from The FUTang Updating medical REcords (FUTURE) Database. More details and the process of data cleaning have been presented in a previous publication[14].

Diagnostic criteria

The diagnosis of TB was made in accordance with the World Health Organization criteria[15]. All analyses included children aged < 18 years with TB who had either bacteriologically confirmed TB (biological specimen positivity determined via culture, smear microscopy, or World Health Organization-approved rapid diagnostic tests) or clinically diagnosed TB (bacteriological criteria were not fulfilled but a diagnosis of active TB was made by a clinician). This definition included cases that were diagnosed based on X-ray abnormalities or suggestive histology, as well as EPTB cases without laboratory confirmation. PTB was defined as any case of TB that only involved the lung parenchyma or the tracheobronchial tree[15]. EPTB was defined as any case of TB that only involved organs other than the lungs (e.g. pleura, lymph nodes, abdomen, genitourinary tract, skin, joints and bones, and/or meninges). Concurrent extrapulmonary and pulmonary TB (combined TB) was defined as any case of TB that involved both the lungs and organs other than the lungs.

Variables and outcomes

Sociodemographic, TB-related, and outcome variables were extracted from the home page of medical records for each patient. The sociodemographic variables mainly included sex, age, ethnicity, place of residence, and birth weight; the TB-related variables included type of TB, diagnosis during the initial visit, and discharge conditions. The outcome variables were hospitalization frequency, length of hospital stay (LOS), and cost burden of TB. In this study, the total hospitalization expenses were divided into four categories: diagnostic tests, medication, inpatient care, and other expenses. We assessed the cost burden of TB by comparing the simulated out-of-pocket expenditures of TB cases relative to the per capita disposable income. Additionally, we collected data regarding the rural and urban per capita disposable income and family size according to the data from the National Bureau of Statistics (https://data.stats.gov.cn/index.htm). The disposable income was calculated as follows: per capita disposable income (Supplementary Table 1) multiplied by the mean family size (3.17, 3.12, 3.05, and 3.02 members per family from 2015 to 2018). Catastrophic expenditure was defined as ≥ 50% of a family’s disposable income[16] (exchange rate: CNY 7.0 = USD 1.0).

Statistical analysis

Continuous variables were presented as means and standard deviations, while categorical variables were presented as percentages. To examine differences among patients with different types of TB, the Pearson χ2 test or one-way analysis of variance was used as appropriate. Multivariable models were built using “Enter” logistic regression procedures. P-values < 0.05 were considered statistically significant. Data analyses were conducted using Statistical Package for the Social Sciences software, version 19.0 (SPSS Inc., Chicago, IL, USA) and JMP software, version 14.0.0 (SAS Institute Inc., Cary, NC, USA). All TB cases were coded according to their province of residence (geo-coded) and were matched to a 1:100,000 digital map of China using ArcGIS software (ArcGIS 10; ESRI Inc., Redlands, CA, USA). The map was coloured according to the six major regions of China’s geographical divisions: North, Northeast, East, Central South, Southwest, and Northwest.

Results

Distribution of the participating hospitals and cases

We collected discharge data regarding 4,654 TB patients from nine provincial and 13 municipal hospitals in China from October 2015 to December 2018. Among these patients, 54.23% (2,524) had PTB, 17.77% (827) had EPTB, and 28.00% (1,303) had combined TB. The 22 research centres in this study were located in 21 provinces across all six regions of China, including six centres in East China, five centres in Central South China, five centres in Northwest China, three centres in North China, two centres in Southwest China, and one centre in Northeast China (Figure 1). The six centres with the largest numbers of cases were Beijing Children’s Hospital (n  = 1342), Hunan Children’s Hospital (n = 741), Women and Children’s Hospital of Qinghai (n = 468), Jinan Children’s Hospital (n = 344), Kunming Children’s Hospital (n = 337), and Jiangxi Children’s Hospital (n = 223) (Supplementary Table 2 and Figure 2).
Figure 1.

Distribution of participating hospitals comprising provincial (orange colour) and municipal hospitals (blue colour).

Figure 2.

Distribution of pediatric TB cases among hospitals in our study.

Distribution of participating hospitals comprising provincial (orange colour) and municipal hospitals (blue colour). Distribution of pediatric TB cases among hospitals in our study. The overall male-to-female ratio of pediatric TB cases was 1.53 (2813/1841), and the rate of low birth weight was 8.21%. The mean age was 5.15 years; 37.57% and 34.06% of the patients were aged 1–3 and > 6 years, respectively. In total, 1633 (35.09%) patients were diagnosed with TB during the first visit. The mean frequency of hospitalization with TB was 2.77 times, and the mean LOS was 9.68 days. Furthermore, 4,040 (86.81%) patients were discharged based on the physician’s discretion, while 336 (7.22%) were discharged against medical advice and 18 died (Table 1 and Supplementary Figure 1).
Table 1.

Characteristics of EPTB and combined TB pediatric patients compared with PTB pediatric patients, China, 2015–2018.

CharacteristicNData not available n (%)Total TBPTBEPTBCombined TBχ2/FP-value
(N=4654)(N=2524)(N=827)(N=1303)
n (%)/Mean±SDn (%)/Mean±SDn (%)/Mean±SDn (%)/Mean±SD
Boy46540(0.00)2813(60.44)1500(59.43)515(62.27)798(61.24)2.590.274
Age, y46531(0.02)5.15±4.454.92±4.424.72±4.535.84±4.3791.050.000
<1  527(11.33)321(12.72)132(15.96)74(5.68)  
1-3  1748(37.57)977(38.72)323(39.06)448(34.38)  
4-6  793(17.04)413(16.37)120(14.51)260(19.95)  
>6  1585(34.06)812(32.18)252(30.47)521(39.98)  
Race/ethnicity46540(0.00)    74.620.000
Han  3844(82.60)2101(83.24)724(87.55)1019(78.20)  
Tibetan  388(8.34)220(8.72)27(3.26)141(10.82)  
Hui  71(1.53)40(1.58)20(2.42)11(0.84)  
Yi  50(1.07)18(0.71)9(1.09)23(1.77)  
Uighur  49(1.05)16(0.63)12(1.45)21(1.61)  
Other  252(5.41)129(5.11)35(4.23)88(6.75)  
Low birth weight*9743680(79.07)80(8.21)42(6.97)23(17.69)15(6.22)18.010.000
Tuberculosis was diagnosed at the first visit46540(0.00)1633(35.09)875(34.67)175(21.16)583(44.74)123.950.000
Discharge46540(0.00)    60.310.000
Leave the hospital on doctor's order  4040(86.81)2269(89.90)692(83.68)1079(82.81)  
Discharged without a doctor's advice  336(7.22)143(5.67)70(8.46)123(9.44)  
Transfer to another hospital as directed by the doctor  132(2.84)61(2.42)21(2.54)50(3.84)  
Death  18(0.39)6(0.24)8(0.97)4(0.31)  
Other¶  128(2.75)45(1.78)36(4.35)47(3.61)  
Length of stay (LOS), d46540(0.00)9.68±11.508.56±10.6010.61±11.2711.27±12.9959.650.000
<7  2976(63.94)1511(59.87)415(50.18)690(52.95)  
7-14  768(16.50)606(24.01)226(27.33)286(21.95)  
>14  910(19.55)407(16.13)186(22.49)327(25.1)  
Rehospitalization plan within one month after discharge46540(0.00)330(7.09)197(7.81)36(4.35)97(7.44)11.610.003
Hospitalization frequency46540(0.00)2.77±4.223.16±4.822.43±3.342.21±3.2779.240.000
1  2976(63.94)1495(59.23)550(66.51)931(71.45)  
2-3  768(16.50)425(16.84)141(17.05)202(15.5)  
>4  910(19.55)604(23.93)136(16.44)170(13.05)  
TB cases that received Bacillus Calmette–Guérin vaccination#13253329(71.53)1106(83.47)579(81.21)212(90.99)315(83.11)12.230.002
TB case verification#13423312(71.16)      
Bacteriologically confirmed TB case  401(29.88)257(35.55)46(19.41)98(25.65)26.7360.000
Clinically diagnosed TB case  941(70.12)466(64.45)191(80.59)284(74.35)  

*Born weight less than 5 pounds, 8 ounces (2,500 grams)

Data extracted from Beijing Children's Hospital

Unexpected conditions of discharges

Characteristics of EPTB and combined TB pediatric patients compared with PTB pediatric patients, China, 2015–2018. *Born weight less than 5 pounds, 8 ounces (2,500 grams) Data extracted from Beijing Children's Hospital Unexpected conditions of discharges According to data from Beijing Children's Hospital, the largest of the 22 research centres, 83.47% (n = 1106) of the pediatric TB cases received the Bacillus Calmette–Guérin vaccine. Bacteriologically confirmed TB cases and clinically diagnosed TB cases constituted 29.88% (n = 401) and 70.12% (n = 941) of the total cases, respectively.

Comparison of pediatric patient characteristics among PTB, EPTB, and combined TB groups

We assessed the characteristics of patients in the PTB, EPTB, and combined TB groups (Table 1). The overall male-to-female ratios in the three groups were 1.46 (1500/1024), 1.65 (515/312), and 1.58 (798/505), respectively. There were no significant differences in terms of sex (P = 0.274). EPTB patients were significantly younger than PTB and combined TB patients (4.72 years vs. 4.92 and 5.84 years, P < 0.001). Concerning ethnicity, the proportion of Han people was significantly greater in the EPTB group than in the PTB or combined TB groups (87.55% vs. 83.24% and 78.20%, P < 0.001). Compared with PTB (42, 6.97%) and combined TB (15, 6.22%), EPTB (23, 17.69%) was more commonly observed in children with low birth weight (P < 0.001). However, the proportion of patients diagnosed at the first visit was lower among patients with EPTB (175, 21.16%) than among patients with PTB (875, 34.67%) or combined TB (583, 44.74%) (P < 0.001). Compared with PTB, EPTB and combined TB were associated with lower hospitalization frequency (2.43 and 2.21 vs. 3.16 times, P < 0.001), longer LOS (10.61 and 11.27 vs. 8.56 days, P < 0.001), and higher rate of discharge against medical advice (8.46% and 9.44% vs. 5.67%, P < 0.001). Patients with EPTB had higher mortality (0.97% vs. 0.24% and 0.31%, P < 0.001) and worse hospitalization plan situation (rehospitalization plan within one month after discharge, 4.35% vs. 7.81% and 7.44%, P = 0.003) than did patients with PTB or combined TB. Data from Beijing Children's Hospital showed that 81.21% of PTB cases, 90.99% of EPTB cases, and 83.11% of combined TB cases received the Bacillus Calmette–Guérin vaccine (P = 0.002). Bacteriologically confirmed TB cases constituted 35.55%, 19.41% and 25.65% of the PTB, EPTB, and combined TB groups, respectively (P < 0.001).

Demographic and clinical characteristics according to forms of EPTB

Among the 2,130 patients with extrapulmonary infection (including 827 EPTB and 1303 combined TB cases) in our study, the most frequent form was meningitis TB (n = 728, 34.18%). Additional forms were pleurisy TB (n = 408, 19.15%), lymphatic TB (n = 390, 18.31%), abdominal TB (n = 310, 14.55%), disseminated TB (n = 237, 11.13%), skeletal TB (n = 204, 9.58%), genitourinary TB (n = 84, 3.94%), and other EPTB (n = 45, 2.11%) (Figure 3).
Figure 3.

EPTB disease sites among 2,130 pediatric patients in China, 2015–2018.

EPTB disease sites among 2,130 pediatric patients in China, 2015–2018. We investigated the associations of pediatric EPTB factors with various demographic and clinical characteristics (Tables 2 and 3). Multivariate logistic modelling analysis showed that children aged 1–3 years had a higher risk of meningitis TB (aOR: 3.13, 95% CI: 1.56–6.26); children aged 4–6 years had higher risks of meningitis TB (aOR: 4.30, 95% CI: 1.98–9.37) and pleurisy TB (aOR: 22.79, 95% CI: 4.23–122.75); and children aged > 6 years had higher risks of meningitis TB (aOR: 2.72, 95% CI: 1.30–5.71), pleurisy TB (aOR: 24.31, 95% CI: 5.20–113.57), and abdominal TB (aOR: 2.86, 95% CI: 1.17–7.00). Tibetan children had a higher risk of meningitis TB (aOR: 3.76, 95% CI: 2.31–6.13) but lower risks of pleurisy TB (aOR: 0.12, 95% CI: 0.05–0.28) and genitourinary TB (aOR: 0.17, 95% CI: 0.03–0.82); Uighur children had a higher risk of abdominal TB (aOR: 73.36, 95% CI: 6.40–840.90). Abdominal TB was more commonly observed in children with low birth weight (aOR: 8.37, 95% CI: 3.78–18.51). Meningitis TB patients had a shorter LOS [7–14 days (aOR: 0.29, 95% CI: 0.15–0.57) and > 14 days (aOR: 0.56, 95% CI: 0.34–0.91)], whereas pleurisy TB patients had a longer LOS [> 14 days (aOR: 2.60, 95% CI: 1.06–6.38)]. Pleurisy TB patients (aOR: 3.28, 95% CI: 1.08–10.02) and skeletal TB patients (aOR: 4.68, 95% CI: 1.27–17.23) had higher rates of discharge against medical advice. Meningitis TB patients (aOR: 8.19, 95% CI: 1.41–47.59) and abdominal TB patients (aOR: 7.38, 95% CI: 1.04–52.45) had higher rates of mortality. Unexpected discharge conditions were observed more frequently among meningitis TB patients (aOR: 15.08, 95% CI: 3.54–64.20) and disseminated TB patients (aOR: 71.82, 95% CI: 11.44–450.84). Meningitis TB patients had a higher rate of catastrophic expenditure (aOR: 5.59, 95% CI: 3.02–10.35).
Table 2.

Demographic and clinical characteristics according to forms of EPTB, China, 2015–2018.

CharacteristicMeningitis TB, n =728, (%)Pleurisy TB, n =408, (%)Lymphatic TB, n =390, (%)Abdominal TB, n =310, (%)Disseminated TB, n =237, (%)Skeletal TB, n =204, (%)Genitourinary TB, n =84, (%)Other EPTB, n =45, (%)
Sex        
Boy446(61.26)266(65.20)233(59.74)174(56.13)162(68.35)130(63.73)48(57.14)30(66.67)
Girl282(38.74)142(34.80)157(40.26)136(43.87)75(31.65)74(36.27)36(42.86)15(33.33)
Age, y        
<158(7.97)3(0.74)66(16.92)20(6.45)60(25.32)5(2.45)22(26.19)8(17.78)
1-3328(45.05)55(13.48)185(47.44)85(27.42)132(55.70)67(32.84)36(42.86)18(40)
4-6139(19.09)97(23.77)46(11.79)47(15.16)18(7.59)59(28.92)9(10.71)5(11.11)
>6203(27.88)253(62.01)93(23.85)158(50.97)27(11.39)73(35.78)17(20.24)14(31.11)
Race/ethnicitya        
Han nationality534(73.35)363(88.97)334(85.64)257(82.90)200(84.39)168(82.35)80(95.24)43(95.56)
Tibetan105(14.42)11(2.70)27(6.92)18(5.81)8(3.38)10(4.90)2(2.38)0(0.00)
Hui6(0.82)3(0.74)5(1.28)3(0.97)13(5.49)4(1.96)0(0.00)0(0.00)
Uighur16(2.20)1(0.25)4(1.03)10(3.23)4(1.69)3(1.47)1(1.19)0(0.00)
Other67(9.20)30(7.35)20(5.13)22(7.10)12(506)19(9.31)1(1.19)2(4.44)
Low birth weight*        
Yes14(8.64)1(2.56)1(1.43)20(35.71)0(0.00)0(0.00)4(15.38)1(14.29)
No148(91.36)38(97.44)69(98.57)36(64.29)13(100.00)17(100.00)22(84.62)6(85.71)
Tuberculosis was diagnosed at the first visit        
Yes311(42.72)122(29.90)134(34.36)92(29.68)150(63.29)108(52.94)4(4.76)1(2.22)
No417(57.28)286(70.10)256(65.64)218(70.32)87(36.71)96(47.06)80(95.24)44(97.78)
Length of stay(LOS), d        
<7370(50.82)220(53.92)231(59.23)149(48.06)137(57.81)95(46.57)27(32.14)20(44.44)
7-14118(16.21)116(28.43)104(26.67)77(24.84)41(17.30)60(29.41)34(40.48)18(40.00)
>14240(32.97)72(17.65)55(14.10)84(27.10)59(24.89)49(24.02)23(27.38)7(15.56)
Hospitalization frequency        
1497(68.27)302(74.02)258(66.15)219(70.65)121(51.05)149(73.04)56(66.67)34(75.56)
2-3121(16.62)54(13.24)55(14.10)50(16.13)49(20.68)28(13.73)20(23.81)8(17.78)
>4110(15.11)52(12.75)77(19.74)41(13.23)67(28.27)27(13.24)8(9.52)3(6.67)
Discharge        
Leave the hospital on doctor's order555(76.24)359(87.99)344(88.21)260(83.87)201(84.81)163(79.9)79(94.05)42(93.33)
Discharged without a doctor's advice94(12.91)21(5.15)31(7.95)31(10.00)19(8.02)17(8.33)3(3.57)2(4.44)
Transfer to another hospital as directed by the doctor33(4.53)19(4.66)4(1.03)8(2.58)5(2.11)6(2.94)1(1.19)0(0.00)
Death9(1.24)0(0.00)0(0.00)4(1.29)3(1.27)0(0.00)0(0.00)0(0.00)
Other*37(5.08)9(2.21)11(2.82)7(2.26)9(3.8)18(8.82)1(1.19)1(2.22)
Catastrophic expenditure        
Yes129(17.72)15(3.68)19(4.87)25(8.06)24(10.13)13(6.37)6(7.14)4(8.89)
No599(82.28)393(96.32)371(95.13)285(91.94)213(89.87)191(93.63)78(92.86)41(91.11)

* Unexpected conditions of discharges

Table 3.

Multivariate analysis of associated factors for different forms of EPTB, China, 2015–2018.

Characteristic Adjusted Odds Ratio(95%CI)
Meningitis TB, n =728Pleurisy TB, n =408Lymphatic TB, n =390Abdominal TB, n =310Disseminated TB, n =237Skeletal TB, n =204Genitourinary TB, n =84Other EPTB, n =45
Sex        
BoyReferentReferentReferentReferentReferentReferentReferentReferent
Girl1.1(0.75-1.62)1.06(0.53-2.14)0.89(0.54-1.48)0.90(0.49-1.65)0.45(0.13-1.62)1.83(0.61-5.5)0.63(0.28-1.43)1.98(0.36-10.84)
Age, y        
<1ReferentReferentReferentReferentReferentReferentReferentReferent
1-33.13(1.56-6.26)4.43(0.87-22.48)0.96(0.48-1.91)1.47(0.61-3.58)0.69(0.12-3.81)-0.65(0.23-1.84)1.47(0.29-7.38)
4-64.30(1.98-9.37)22.79(4.23-122.75)0.36(0.12-1.08)1.71(0.54-5.38)0.54(0.06-4.55)-0.24(0.02-2.57)-
>62.72(1.30-5.71)24.31(5.20-113.57)0.68(0.31-1.52)2.86(1.17-7.00)0.36(0.05-2.79)-1.02(0.31-3.41)-
Race/ethnicitya        
Han nationalityReferentReferentReferentReferentReferentReferentReferentReferent
Tibetan3.76(2.31-6.13)0.12(0.05-0.28)0.99(0.52-1.87)0.58(0.27-1.26)1.93(0.41-9.14)0.63(0.18-2.27)0.17(0.03-0.82)-
Hui1.31(0.39-4.34)0.17(0.02-1.53)0.64(0.08-5.13)0.91(0.22-3.81)-1.03(0.1-11.1)--
Uighur---73.36(6.40-840.9)--7.06(0.53-94.82)-
Other2.59(1.05-6.42)0.14(0.02-1.16)0.37(0.05-2.89)1.87(0.55-6.38)-2.29(0.36-14.57)--
Low birth weight*        
Yes1.42(0.68-2.99)0.42(0.05-3.41)0.14(0.02-1.05)8.37(3.78-18.51)--1.25(0.36-4.33)0.84(0.07-9.71)
NoReferentReferentReferentReferentReferentReferentReferentReferent
Tuberculosis was diagnosed at the first visit     
YesReferentReferentReferentReferentReferentReferentReferentReferent
No1.04(0.68-1.58)0.57(0.27-1.21)0.8(0.44-1.46)1.17(0.54-2.53)0.54(0.13-2.24)0.35(0.12-1.01)7.93(0.94-66.69)-
Length of stay(LOS), d     
<7ReferentReferentReferentReferentReferentReferentReferentReferent
7-140.29(0.15-0.57)2.44(0.99-5.98)0.76(0.38-1.51)0.94(0.42-2.12)-1.38(0.35-5.45)0.93(0.3-2.88)0.56(0.09-3.55)
>140.56(0.34-0.91)2.60(1.06-6.38)0.61(0.3-1.23)0.92(0.42-2.02)1.51(0.33-6.83)1.40(0.41-4.79)1.07(0.32-3.6)0.34(0.03-4.15)
Hospitalization frequency       
1ReferentReferentReferentReferentReferentReferentReferentReferent
2-30.78(0.43-1.42)0.43(0.12-1.53)0.64(0.27-1.51)0.64(0.22-1.85)1.86(0.32-10.73)-1.62(0.5-5.27)0.90(0.09-8.72)
>40.76(0.35-1.69)-0.76(0.3-1.9)---0.81(0.09-7.08)-
Discharge        
Leave the hospital on doctor's orderReferentReferentReferentReferentReferentReferentReferentReferent
Discharged without a doctor's advice1.34(0.71-2.53)3.28(1.08-10.02)0.64(0.22-1.85)2.39(0.98-5.88)2.26(0.4-12.61)4.68(1.27-17.23)--
Transfer to another hospital as directed by the doctor1.48(0.28-7.7)1.75(0.19-16.29)-0.54(0.06-5.19)-4.12(0.34-49.41)--
Death8.19(1.41-47.59)--7.38(1.04-52.45)----
Other*15.08(3.54-64.20)-2.59(0.49-13.74)2.16(0.23-20.08)71.82(11.44-450.84)---
Catastrophic expenditure         
Yes5.59(3.02-10.35)-0.63(0.2-1.98)0.38(0.1-1.45)1.50(0.29-7.83)0.89(0.1-8.08)1.10(0.29-4.19)-
NoReferentReferentReferentReferentReferentReferentReferentReferent

* Unexpected conditions of discharges

Demographic and clinical characteristics according to forms of EPTB, China, 2015–2018. * Unexpected conditions of discharges Multivariate analysis of associated factors for different forms of EPTB, China, 2015–2018. * Unexpected conditions of discharges The forms of EPTB differed among age groups. The ages of patients with meningitis TB (4.58 years), lymphatic TB (4.03 years), disseminated TB (2.43 years), and genitourinary TB (3.28 years) were significantly younger than the mean age (5.15 years) of patients with pediatric TB (P < 0.001), and pleurisy TB (8.16 years) and abdominal TB (7.05 years) were comparatively older (P < 0.001) (Supplementary Table 3). Among children aged < 3 years, disseminated TB, genitourinary TB, lymphatic TB, other EPTB, and meningitis TB (81.01%, 69.05%, 64.36%, 57.78%, and 53.02%) were more common than PTB (51.45%) (Figure 4).
Figure 4.

Age distributions of PTB and forms of EPTB in China, 2015–2018.

Age distributions of PTB and forms of EPTB in China, 2015–2018.

Medical expenses and cost burden of PTB, EPTB, and combined TB

Among all pediatric TB cases in our study, the mean total and out-of-pocket medical expenses were $2124.85 and $1517.69, respectively. The mean diagnostic test expenses, medication expenses, inpatient care expenses, and other expenses were $650.97, $660.59, $751.60, and $63.06, respectively. According to the per capita disposable income of each province, the overall cost burden of TB was 15.09%; the rate of catastrophic expenditure was 6.88% (320/4654). The total ($2486.41 and $2460.76 vs. $1832.98, P < 0.001) and out-of-pocket ($1772.62 and $1670.18 vs. $1355.44, P < 0.001) hospitalization expenses were significantly higher for EPTB and combined TB than for PTB. EPTB and combined TB also had higher financial burdens (17.67% and 16.94% vs. 13.30%, P < 0.001) and higher rates of catastrophic expenditure (8.22% and 9.59% vs. 5.03%, P < 0.001), compared with PTB (Table 4). Furthermore, EPTB and combined TB patients had higher expenses in terms of diagnosis ($697.91 and $699.72 vs. $610.41, P = 0.001), medication ($835.32 and $828.68 vs. $516.51, P < 0.001), inpatient care ($894.17 and $857.07 vs. $650.40, P < 0.001), and other expenses ($59.01 and $77.17 vs. $57.11, P = 0.019), compared with PTB patients. However, the proportions of diagnostic expenses (compared to overall expenses) were lower for EPTB and combined TB patients than for PTB patients (28.07% and 28.41% vs. 33.28%) (Figure 6 and Table 4).
Table 4.

Distribution of hospitalization expenses by different TB types, China, 2015–2018.

VariableDiagnostic tests expenses, USDMedication expenses, USDInpatient care expenses, USDOther expenses, USDTotal hospitalization expenses, USDOut-of pocket hospitalization expenses, USDCost burden, %Catastrophic expenditure, n(%)
Total TB650.97±809.76660.59±1273.22751.60±1357.7763.06±214.032124.85±3057.321517.69±2713.0515.09±27.67320(6.88)
PTB610.41±874.07516.51±1015.81650.40±1199.3757.11±186.271832.98±2793.881355.44±2436.6913.30±23.65127(5.03)
EPTB697.91±734.76835.32±1542.91894.17±1432.4259.01±164.932486.41±3303.031772.62±3127.4417.67±33.6868(8.22)
Combined TB699.72±716.57828.68±1481.63857.07±1566.8777.17±280.992460.76±3316.041670.18±2911.8416.94±30.31125(9.59)
F/χ26.9335.8115.593.9625.4110.2611.8830.78
P-value0.0010.0000.0000.0190.0000.0000.0000.000
Meningitis TB873.31±908.84***1254.85±2010.71***1155.24±1773.82***102.14±251.28***3385.54±4324.76***2353.59±4021.83***24.43±42.23***129(17.72)***
Pleurisy TB608.03±382.5*597.62±754.36***584.59±886.47***62.42±337.881848.12±1678.69**1355.30±1727.1213.63±18.3315(3.68)**
Lymphatic TB553.7±632.16*495.69±919.25***637.75±868.67*35.99±126.4***1723.14±2171.57***1447.01±2240.5114.07±23.1819(4.87)
Abdominal TB842.63±829.57***1146.36±1742.77***861.16±1300.9369.96±261.562920.11±3554.87***1727.00±3097.0317.30±35.3525(8.16)
Disseminated TB637.23±672.39973.55±1778.64**929.23±1323.85*53.19±156.032593.20±3432.51*1953.56±3209.64*19.68±33.93**24(10.13)*
Skeletal TB505.22±385.91***443.22±1327.81*1179.70±2619.79*36.78±65.81***2164.92±3396.381363.16±2958.8313.87±31.6113(6.37)
Genitourinary TB619.63±530.71455.67±475.17***702.77±852.7248.48±100.951826.54±1725.561729.66±1787.1316.08±16.186(7.14)
Other EPTB653.70±618.3561.34±597.49692.60±953.3873.27±201.031980.91±1929.81702.57±2076.6316.20±19.824(8.89)

*P≤0.05

**P≤0.01

***P≤0.001

Figure 6.

Expenses of PTB and forms of EPTB in China, 2015–2018.

Distribution of hospitalization expenses by different TB types, China, 2015–2018. *P≤0.05 **P≤0.01 ***P≤0.001 Analysis of hospitalization expenses among forms of EPTB showed that the three types of EPTB with the highest total hospitalization expenses were meningitis TB ($3385.54), abdominal TB ($2920.11), and disseminated TB ($2593.20). Additionally, meningitis TB ($2353.59), disseminated TB ($1953.56), and genitourinary TB ($1729.66) had the highest out-of-pocket hospitalization expenses. According to the per capita disposable income of each province, the cost burden and the rate of catastrophic expenditure among different EPTB forms ranged from 24.43% to 13.63% and 17.72% to 3.68%, respectively; both values were highest for meningitis TB (Figure 5 and Table 4). Concerning the forms of hospitalization expenses, meningitis TB had the highest diagnostic test expenses ($873.31), medication expenses ($1254.85), and other expenses ($102.14); it had the second highest ($1155.24) inpatient care expenses after skeletal TB ($1179.70) (Table 4). Among the three types of EPTB with the greatest cost burdens, medication constituted the greatest proportion of expenses (meningitis TB, 37.06%; disseminated TB, 39.26%; and genitourinary TB, 37.54%). Inpatient care constituted the greatest proportion of expenses among skeletal TB (54.49%), genitourinary TB (38.48%), lymphatic TB (37.01%), and other EPTB (34.96%). For pleurisy TB, diagnostic tests constituted the greatest proportion of expenses (32.90%) (Figure 6 and Table 4).
Figure 5.

Hospitalization expenses among 4,654 pediatric patients in China, 2015–2018. A) Total hospitalization expenses of PTB and forms of EPTB. B) Out-of-pocket hospitalization expenses of PTB and forms of EPTB. C) Cost burdens of PTB and forms of EPTB. D) Catastrophic expenditures of PTB and forms of EPTB.

Hospitalization expenses among 4,654 pediatric patients in China, 2015–2018. A) Total hospitalization expenses of PTB and forms of EPTB. B) Out-of-pocket hospitalization expenses of PTB and forms of EPTB. C) Cost burdens of PTB and forms of EPTB. D) Catastrophic expenditures of PTB and forms of EPTB. Expenses of PTB and forms of EPTB in China, 2015–2018.

Discussion

We described the epidemiological characteristics of pediatric patients with EPTB in China based on multicenter data obtained from 22 pediatric hospitals throughout mainland China. This representative study contained the largest number of hospitalized pediatric patients with EPTB. To our knowledge, this is the first study to demonstrate the severe epidemic of pediatric EPTB in China. Nearly 46% of children in this study exhibited EPTB or combined TB; this was higher than the proportions in the UK (38.11%)[17], Colombia (34.41%)[18], Italy (30.87%)[19], Turkey (30.50%)[20], the USA (24.52%)[21], and India (17.68%)[22]. Previous studies of Chinese pediatric TB patients from Beijing Children’s Hospital and Shandong Chest Hospital showed that the overall proportions of pediatric TB patients with extrapulmonary infection were 54% and 73%, respectively[12, 13]. A plausible explanation for the differences between the present and previous studies was that both previous studies used single-centre designs and were conducted at high-level hospitals in the eastern part of China which had relatively better medical diagnosis and treatment capabilities countrywide. Thus, these hospitals might diagnose and treat more EPTB patients, compared with other centres. Additionally, our data showed that meningitis TB was the predominant type of extrapulmonary infection among inpatients in China, constituting nearly 34.18% of all EPTB and combined TB cases. This result was consistent with a previous finding at Beijing Children’s Hospital (38.8%)[12], although it differed from the finding in Shandong Province that pleural TB (29.0%) was the most common type of pediatric EPTB[13]. A possible explanation for this difference is that the mean age of EPTB cases was older (9.26 years) in the study from Shandong Province, compared with the mean ages of EPTB cases in our study (5.15 years) and in the study from Beijing Children's Hospital (5.5 years). Our study indicated that pleural TB mainly occurred in children aged > 6 years (62.01%), while meningitis TB mainly occurred in children aged < 6 years (72.12%). Therefore, differing age distributions among patients in the above studies may have led to distinct distributions of EPTB forms. Significant differences have been observed between pediatric and adult EPTB in China. Specifically, the proportions of PTB, EPTB, and combined TB differ between pediatric and adult TB. The overall proportion of children with extrapulmonary infection (45.76%) was much higher than the overall proportion of adults with extrapulmonary infection (37.44%)[23]. Furthermore, the forms of EPTB differ between pediatric and adult patients. In a study of 19,279 TB patients (6433 EPTB cases) who were hospitalized in Beijing Chest Hospital, the most common types of EPTB were skeletal TB (41.1%) and pleural TB (26.0%). Meningitis TB only constituted 6.8% of the EPTB cases[23]. Another study of 202,998 EPTB inpatients aged ≥ 15 years from 21 hospitals, most of which specialize in TB, showed that the most common type of EPTB was pleural TB (50.15%); only 7.23% of patients exhibited meningitis TB[24]. In our study, the incidence rate of meningitis TB was high in children (34.18%); it was highest in the 1–3-year-old and 4–6-year-old age groups, followed by the > 6-year-old and < 1-year-old age groups. We found that the diagnostic rate during the first visit was significantly lower for EPTB than for PTB or combined TB (21.16% vs. 34.67% and 44.74%). The low bacterial load in non-respiratory specimens often obscures detection, while sample collection from deep tissues is challenging; thus, EPTB poses a diagnostic challenge[25]. The diagnosis of EPTB is often missed or made at an advanced stage of the disease when complications have already begun [6]. Considering the suboptimal sensitivities of existing immunological and microbiological TB tests in children, the combined use of immune-based tests with culture and nucleic acid amplification tests provides substantially higher positive diagnostic yields; therefore, it should be standard clinical practice in high-resource settings [26]. Additionally, TB diagnostic tests have been developed and largely validated in adults with pulmonary TB [27]. Research focusing on the development and validation of biomarkers or tools in children should be encouraged, particularly concerning tests that may be useful in the diagnosis of EPTB. The burden of EPTB in children is considerable and requires greater investment of public health effort. Compared with PTB, EPTB and combined TB were associated with higher costs, causing a significant burden for the families of affected patients. The respective mean cost burdens were 35.65% and 34.25% higher for EPTB and combined TB than for PTB ($2486.41 and $2460.76 vs. $1832.98). Moreover, compared with PTB, EPTB and combined TB were associated with higher rates of discharge against medical advice and worse hospitalization plan situation. Therefore, strengthening publicity and management of pediatric EPTB are required to optimize the completion of its standardized treatment. Among the forms of EPTB in pediatric patients, meningitis TB requires additional consideration. Compared with other forms of EPTB, meningitis TB constitutes a greater proportion (34.18%), is present in younger patients (4.58 years), has higher costs ($3385.54), and carries the highest risk of catastrophic expenditure (8.19-fold). Previous studies showed that young children and people living with human immunodeficiency virus (HIV) have the highest risks of TB meningitis [28-30]; moreover, meningitis TB is the most severe type of TB [31, 32]. Therefore, because of the high incidence and generally high risk of death of tuberculous meningitis among Chinese children, the prevention and treatment of meningitis TB in children should be a high-priority public health focus. Further research is needed concerning the diagnosis and treatment [33-35] of meningitis TB. The current study had three limitations. First, the retrospective design did not involve collection of national surveillance data, potentially limiting the overall relevant scope of the findings. Unfortunately, because EPTB does not substantially contribute to the transmission of TB, it has not been included in China’s National TB Control Programme. Consequently, the acquisition of national surveillance data has been challenging. Second, all children enrolled in our study were HIV-negative. HIV infection has been considered an additional risk factor for EPTB [36, 37]. However, children co-infected with TB and HIV were referred to other hospitals that specialize in HIV treatment in China. The absence of patients co-infected with HIV and TB in this study may have led to some bias in our results. Third, the results of Bacillus Calmette–Guérin vaccination and microbiological confirmation were based on single-centre data, and some important data (e.g. tuberculin skin test and interferon-gamma release assay findings) were not available for analysis.

Conclusion

This study described the epidemiological and financial burden of EPTB among patients from nine provincial and 13 municipal hospitals in mainland China. Compared with PTB, pediatric EPTB was associated with a longer LOS and higher cost burden. The most common type of EPTB in children was meningitis TB, which is the most severe type of TB. Pediatric EPTB should receive greater investment of public health effort. Efforts to improve screening approaches for EPTB are needed to reduce the associated diagnostic challenges and financial burden. Therefore, improved screening, enhanced educational efforts, and policy prioritization is essential for adequate management of EPTB. Finally, additional research is needed concerning the diagnosis and treatment[34, 38] of meningitis TB. Click here for additional data file.
  34 in total

1.  Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort Study.

Authors:  Christopher Vinnard; Liza King; Sonal Munsiff; Aldo Crossa; Kentaro Iwata; Jotam Pasipanodya; Douglas Proops; Shama Ahuja
Journal:  Clin Infect Dis       Date:  2017-02-15       Impact factor: 9.079

2.  Disease spectrum analysis of hospitalized children in China: A study of 18 tertiary children's hospitals.

Authors:  Guoshuang Feng; Yueping Zeng; Jian Tian; Xinyu Wang; Jun Tai; Fei Song; Xin Zhang; Xin Xu; Jun Chen; Tieliu Shi; Xin Ni
Journal:  Pediatr Investig       Date:  2019-09-26

3.  Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children.

Authors:  Nathella Pavan Kumar; R Anuradha; Bruno B Andrade; N Suresh; R Ganesh; Janani Shankar; V Kumaraswami; Thomas B Nutman; Subash Babu
Journal:  Clin Vaccine Immunol       Date:  2013-03-13

4.  Improved case detection using Xpert Mycobacterium tuberculosis/rifampicin assay in skeletal tuberculosis.

Authors:  Swapna Rajesh Kanade; Gita Nataraj; Preeti Rajiv Mehta
Journal:  Indian J Med Microbiol       Date:  2018 Oct-Dec       Impact factor: 0.985

5.  Differences between pediatric extra-pulmonary and pulmonary tuberculosis: a warning sign for the future.

Authors:  Ilker Devrim; Hüseyin Aktürk; Nuri Bayram; Hurşit Apa; Sener Tulumoğlu; Fatma Devrim; Tülin Erdem; Gamze Gulfidan; Yüce Ayhan; Ipek Tamsel; Demet Can; Hüdaver Alper
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-09-01       Impact factor: 2.576

6.  Under-reporting of diagnosed tuberculosis to the national surveillance system in China: an inventory study in nine counties in 2015.

Authors:  Xin Du; Lixia Wang; Tao Li; Hemant Deepak Shewade; Kyaw Thu Soe; Jeanette J Rainey; Hui Zhang
Journal:  BMJ Open       Date:  2019-01-28       Impact factor: 2.692

Review 7.  The pathogenesis of tuberculous meningitis.

Authors:  Angharad Grace Davis; Ursula Karin Rohlwink; Alizé Proust; Anthony A Figaji; Robert J Wilkinson
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

8.  Electronic recording and reporting system for tuberculosis in China: experience and opportunities.

Authors:  Fei Huang; ShiMing Cheng; Xin Du; Wei Chen; Fabio Scano; Dennis Falzon; Lixia Wang
Journal:  J Am Med Inform Assoc       Date:  2013-12-10       Impact factor: 4.497

9.  Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study.

Authors:  Robindra Basu Roy; Stephanie Thee; Daniel Blázquez-Gamero; Lola Falcón-Neyra; Olaf Neth; Antoni Noguera-Julian; Cristina Lillo; Luisa Galli; Elisabetta Venturini; Danilo Buonsenso; Florian Götzinger; Nuria Martinez-Alier; Svetlana Velizarova; Folke Brinkmann; Steven B Welch; Maria Tsolia; Begoña Santiago-Garcia; Renate Krüger; Marc Tebruegge
Journal:  Eur Respir J       Date:  2020-07-02       Impact factor: 16.671

Review 10.  Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment.

Authors:  Aysha Arshad; Sujay Dayal; Raj Gadhe; Ajinkya Mawley; Kevin Shin; Daniel Tellez; Phong Phan; Vishwanath Venketaraman
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

View more
  2 in total

1.  Treatment of Stage I-III Hip Joint Tuberculosis With Open Surgical Debridement and Hip Spica in Children: A Retrospective Study.

Authors:  Lei Yang; Jingjing Zuo; Lang Li; Daoxi Wang; Xiaodong Yang; Xueyang Tang
Journal:  J Pediatr Orthop       Date:  2022-08-09       Impact factor: 2.537

2.  The value of interleukin-27 for differentiating tuberculous pleural effusion from Mycoplasma pneumoniae pneumonic effusion in children.

Authors:  Hui Xu; Haiming Yang; Jinrong Liu; Hui Liu; Xiaolei Tang; Huimin Li; Siyu Cai; Shunying Zhao
Journal:  Front Pediatr       Date:  2022-07-28       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.